ALEXANDRIA, Va., Oct. 26 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'BRIUMVI-ONE' in its latest official gazette. The trademark application with the serial number 99840452 was filed on May 22, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): TG Therapeutics, Inc. 2 Gansevoort Street, 9th Floor New York NY New York 10014 3 CORPORATION
Disclaimer: Curated by HT Syndication....